Laura Tuzza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Laura Tuzza has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Alessia De Gioia
Neuropsichiatria Infantile Fondazione Policlinico Universitario A. Gemelli IRCCS Rome Italy
1 shared publication C. Arpaia
Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Roma, Italy; Pediatric Neurology Unit, Università Cattolica del Sacro Cuore, 00168, Roma, Italy
1 shared publication- Carolina Giordano
Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico “A. Gemelli” IRCCS, 00168 Rome, Italy
1 shared publication - Chiara Schiarelli
UOSA Neuroradiologia Diagnostica, Fondazione Policlinico Universitario “A. Gemelli” IRCSS, 00168 Rome, Italy
1 shared publication D.M. Romeo
Pediatric Neurology Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168, Roma, Italy; Pediatric Neurology Unit, Università Cattolica del Sacro Cuore, 00168, Roma, Italy
1 shared publication- Fabio Pilato
Fondazione Policlinico Universitario Campus Bio-Medico, 00128 Rome, Italy
1 shared publication
Latest Publications
- Open Access
- 13 June 2025
- Published by Elsevier in Clinical Radiology
- Vol. 88, 106991
Visual-semiquantitative and quantitative magnetic resonance imaging (MRI) data may predict outcome in congenital cytomegalovirus infection
- 13 June 2025
- Published by Elsevier in Clinical Radiology
- Vol. 88, 106991
Open AccessVisual-semiquantitative and quantitative magnetic resonance imaging (MRI) data may predict outcome in congenital cytomegalovirus infection
- Open Access
Advanced Magnetic Resonance Imaging in the Evaluation of Treated Glioblastoma: A Pictorial Essay
MRI plays a key role in the evaluation of post-treatment changes, both in the immediate post-operative period and during follow-up. There are many different treatment’s lines and many different neuroradiological findings according to the treatment chosen and the clinical timepoint at which MRI is performed. Structural MRI is often insufficient to correctly interpret and define treatment-related changes. For that, advanced MRI modalities, including perfusion and permeability imaging, diffusion tensor imaging, and magnetic resonance spectroscopy, are increasingly utilized in clinical practice to characterize treatment effects more comprehensively. This article aims to provide an overview of the role of advanced MRI modalities in the evaluation of treated glioblastomas. For a didactic purpose, we choose to divide the treatment history in three main timepoints: post-surgery, during Stupp (first-line treatment) and at recurrence (second-line treatment). For each, a brief introduction, a temporal subdivision (when useful) or a specific drug-related paragraph were provided. Finally, the current trends and application of radiomics and artificial intelligence (AI) in the evaluation of treated GB have been outlined.
Open AccessAdvanced Magnetic Resonance Imaging in the Evaluation of Treated Glioblastoma: A Pictorial Essay
MRI plays a key role in the evaluation of post-treatment changes, both in the immediate post-operative period and during follow-up. There are many different treatment’s lines and many different neuroradiological findings according to the treatment chosen and the clinical timepoint at which MRI is performed. Structural MRI is often insufficient to correctly interpret and define treatment-related changes. For that, advanced MRI modalities, including perfusion and permeability imaging, diffusion tensor imaging, and magnetic resonance spectroscopy, are increasingly utilized in clinical practice to characterize treatment effects more comprehensively. This article aims to provide an overview of the role of advanced MRI modalities in the evaluation of treated glioblastomas. For a didactic purpose, we choose to divide the treatment history in three main timepoints: post-surgery, during Stupp (first-line treatment) and at recurrence (second-line treatment). For each, a brief introduction, a temporal subdivision (when useful) or a specific drug-related paragraph were provided. Finally, the current trends and application of radiomics and artificial intelligence (AI) in the evaluation of treated GB have been outlined.